HealthQuill Drugs
The Food and Drug Administration has approved Glaukos Corporation’s drug to treat keratoconus, a rare, sight-threatening eye disease that is currently far too often undiagnosed and untreated.
Drugs Health Pharma

US regulator clears Glaukos Corp.’s drug to treat rare eye condition

The Food and Drug Administration has approved Glaukos Corporation’s drug to treat keratoconus, a rare, sight-threatening eye disease that is currently far too.

Read More
Merck and Co. will invest up to $70 billion to expand its domestic manufacturing in the US after President Donald Trump urged pharmaceutical companies to set up their bases within the country and reduce reliance on imports of drugs.
Drugs Health Pharma

Merck to spend $70 billion to expand domestic manufacturing in US

Merck and Co. will invest up to $70 billion to expand its domestic manufacturing in the US after President Donald Trump urged pharmaceutical.

Read More
Novo Nordisk will acquire US-based Akero Therapeutics, Inc. for $5.2 billion to pocket an experimental drug in end-stage trials to treat liver disease, the company announced.
Drugs Health Pharma

Novo to buy Akero for $5.2 billion, to pocket trial liver disease drug

Novo Nordisk will acquire US-based Akero Therapeutics, Inc. for $5.2 billion to pocket an experimental drug in end-stage trials to treat liver disease,.

Read More
Zenas BioPharma, Inc. and China’s InnoCare Pharma Limited have inked a $2 billion licensing deal that grants the US-based Zenas global rights to develop and commercialise an investigational drug to treat multiple sclerosis (MS) and other autoimmune diseases.
Drugs Health Pharma

Zenas, InnoCare in $2b licensing deal for MS, autoimmune diseases

Zenas BioPharma, Inc. and China’s InnoCare Pharma Limited have inked a $2 billion licensing deal that grants the US-based Zenas global rights to.

Read More
US regulator rejects Fortress Biotech’s experimental pediatric medicine 
Drugs Medical Pharma

US regulator rejects Fortress Biotech’s experimental pediatric medicine 

The US regulator has declined to approve an experimental pediatric drug of Fortress Biotech Inc., an American biotechnology company, due to certain production.

Read More
Pfizer Inc., a US pharmaceutical company founded in 1849, has signed an agreement with the Trump administration to lower prices of prescription medicines in the North American nation
Drugs Medical Pharma

Pfizer inks deal with Trump to lower price of prescription drugs in US

Pfizer Inc., a US pharmaceutical company founded in 1849, has signed an agreement with the Trump administration to lower prices of prescription medicines.

Read More
Dopamine rush, brain’s mirror games may help ‘you become what you think’
Drugs Research

Metformin lowers blood sugar by acting in the brain, new research shows

HQ Team September 30, 2025: Until recently, scientists mainly believed that Metformin, used to help control type 2 diabetes, worked by reducing glucose.

Read More
Drugs Health

FDA’s caution to physicians about autism-Tylenol link fuels debate

HQ Team September 23, 2025: The U.S. Food and Drug Administration (FDA) has recently issued a cautionary note regarding the use of acetaminophen.

Read More
Billionaire Bill Gates has pledged $912 million over three years, starting next year, to the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Drugs Health Pharma

Bill Gates to spend $912 million to fight AIDS, tuberculosis, malaria

Billionaire Bill Gates has pledged $912 million over three years, starting next year, to the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Read More
Pfizer Inc. will buy Matsera Inc. for $7.3 billion to eye at least four experimental drugs in the rapidly growing obesity market after it scrapped development of its own weight-loss pill in April this year.
Drugs Health Pharma

Pfizer to buy Matsera Inc. for $7.3 billion, eyes 4 anti-obesity drugs

Pfizer Inc. will buy Matsera Inc. for $7.3 billion to eye at least four experimental drugs in the rapidly growing obesity market after.

Read More